LOGO.png
Nemaura Medical to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
June 01, 2021 08:05 ET | Nemaura Medical, Inc
Loughborough, England, June 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany
May 06, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, May 06, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
May 05, 2021 08:00 ET | Nemaura Medical, Inc
Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE Loughborough, England, May 05, 2021 (GLOBE...
LOGO.png
Nemaura Medical to Conduct Shareholder Update Call April 28, 2021, 4:30PM ET
April 21, 2021 08:10 ET | Nemaura Medical, Inc
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
April 15, 2021 08:07 ET | Nemaura Medical, Inc
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
March 25, 2021 08:10 ET | Nemaura Medical, Inc
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
March 11, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy
March 04, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing
February 04, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...